Kevin James Craig Atai Life Sciences N.V. (ATAI) insider trading activity

ATAI Quotes by TradingView

Kevin James Craig is Chief Medical Officer of ATAI Life Sciences N.V.. Currently has a direct ownership of 8,437 shares of ATAI, which is worth approximately $12,402. The most recent transaction as insider was on Mar 21, 2025, when has been sold 11,563 shares (Common Shares) at a price of $1.35 per share, resulting in proceeds of $15,610. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.44K
n/a 3M change
n/a 12M change
Total Value Held $12,402

Kevin James Craig Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2025
SELL
Open market or private sale
$15,610 $1.35 p/Share
11,563 Reduced 57.82%
8,437 Common Shares
Mar 14 2025
BUY
Exercise of conversion of derivative security
-
20,000 Added 50.0%
20,000 Common Shares
KJC

Kevin James Craig

Chief Medical Officer
Berlin, 2M

Track Institutional and Insider Activities on ATAI

Follow ATAI Life Sciences N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATAI shares.

Notify only if

Insider Trading

Get notified when an Atai Life Sciences N.V. insider buys or sells ATAI shares.

Notify only if

News

Receive news related to ATAI Life Sciences N.V.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATAI